All Financial results articles – Page 35
-
Article
Richemont enjoys strong demand in China but warns that Covid-19 impact may last
As China has become the bellwether on how fast an economy can recover from the Covid-19 crisis, Richemont pointed out that it is currently enjoying strong demand in the country. Nevertheless, it warned that the impact of the virus on the global economy may last a long time.
-
Article
Bausch Health’s Q1 revenues flat
Bausch Health’s sales were constrained by the Covid-19 pandemic but the global consumer and international prescription activities of its Bausch + Lomb eye care division posted strong growth. It expects a recovery from the latter part of the second quarter but nevertheless cut its full-year guidance.
-
Article
Hoya Q4 eyeglass lens sales down 10%, contact lenses more resilient
Like many others, the Covid-19 outbreak has hit Hoya Corporation in its quarterly results. The Japanese group is, however, upbeat on the prospect of recouping from pent-up demand in the eyeglass segment based on signals from China and South Korea, where the pandemic is vaning.
-
Article
Eschenbach in full swing on home turf
Eschenbach has been growing constantly in Germany, becoming the market leader in prescription eyewear. It has also enjoyed strong growth in Europe and the U.S..
-
Article
Fedon raises €5 million in financing
Giorgio Fedon, the Italian producer of eyeglass cases, obtained €5 million in financing from two leading Italian banks, as well as some members of the family that control it, to fund its investments. In 2019, it returned to being profitable, albeit marginally.
-
ArticleEssilorLuxottica’s Q1 sales drop by 10%
EssilorLuxottica’s first-quarter revenues were down by 10.1 percent from the year-ago quarter to €3,784 million, or by 10.9 percent in constant currencies, due to the impact of the Covid-19 pandemic. But, the company is confident that pent-up demand will underpin sales when the crisis is over. Thanks to its financial ...
-
ArticleFielmann’s Q1 sales and profits decline
(updated) Blaming the coronavirus outbreak, Fielmann reported a sharp 74.8 percent drop in net income for the first quarter of 2020, down to €11.8 million, on a 7.0 percent decline in consolidated revenues to €352.9 million for the first quarter of this year. The number of glasses sold fell by ...
-
News briefs
Allergan's Q4 revenues up
Allergan’s fourth-quarter revenues rose by 6.6 percent to $4,351million. The group posted an operating loss of $276.6 million for the period compared with an operating loss of $5,384 million a year earlier. On an adjusted basis, it booked an operating income of $2.079 million, up by 8.4 percent. Allergan expects ...
-
News briefs
Kering Eyewear feeds its parent
Kering Eyewear contributed revenues of €474 million to the turnover of the Kering group in 2019, up by 18.2 percent on a comparable basis from 2018. The rise was fueled by the Gucci, Cartier and Saint Laurent licenses and the takeover of the Montblanc and Balenciaga licenses. With intra-group sales ...
-
Article
Fielmann posts slightly higher profits for the year
Fielmann’s performance for 2019 seems to have confirmed the positive momentum that it had already reported for the first half of the year. According to preliminary figures, its consolidated sales for the 2019 financial year show an increase of about 6 percent to €1.52 billion as compared to €1.43 billion ...
-
Article
Higher sales and profits for Synsam
The Synsam Group reached a turnover of 3,741 million Swedish kronor (€350.7m-$387.4m) last year, up from SEK 3,380 million in 2018. The adjusted operating profit amounted to SEK 984 million (€92.3m-$101.9m) a big increase from SEK 643 million in the previous year. In addition to the opening of new ...
-
Article
Hoya reports a squeeze in segment sales and profits
The results of Hoya Corp. for the third quarter ended on Dec. 31 were negatively impacted by the expected increase in the sales tax in Japan, which had increased purchases in the previous quarter. In particular, sales of contact lenses and eyeglass lenses declined in the country, affecting also the ...
-
Article
Alcon’s first year after Novartis spin-off is a success
Alcon reported total sales of $7,362 million for the full year 2019, an increase of 3 percent on a reported basis and 5 percent in constant currencies. The management said that 2019 was a good year for the company, as it completed its spin-off from Novartis to become an ...
-
Article
Lawsuit widens Bausch Health’s net loss in Q4
Bausch Health reported a net loss of $1,516 million for the fourth quarter, compared with a net loss of $344 million for the year-ago period. The management blamed mainly the accrual of legal reserves established for the resolution of a so-called “stock drop” litigation in the U.S. linked to the ...
-
Article
EssilorLuxottica posts strong sales and profits for 2019
In 2019, the first full year in which Essilor and Luxottica were part of the same company, EssilorLuxottica – alias Essilux – enjoyed a 7.4 percent jump in revenues to €17.390 million on a pro-forma basis. In constant currencies, they grew by 4.4 percent. One of the highlights was a ...
-
News briefs
Afflelou's first half
The Afflelou Group has reported a drop of 8.9 percent in sales at Alain Afflelou stores, many of which are franchised, for the first half of its financial year, ended on Jan. 31, attributing it to the effect in France of new legislation on the reimbursement of consumers’ expenses on ...
-
Article
CooperVision grows by 4% in Q1
CooperVision’s sales went up by 3 percent to $485.2 million in the first quarter of Cooper Companies’ financial year, which ended on Jan. 31, and its gross margin improved by 0.5 percentage points to 66.5 percent. Sales of toric lenses rose by 6 percent to $155.1 million, multifocal lenses ...
-
Article
GrandVision issues profit warning due to Covid-19
Because of the Covid-19 pandemic, GrandVision (GV) no longer expects this year to achieve its medium-term objectives of an annual growth of at least 5 percent in revenue and Ebita. It noted that the business environment remains uncertain but the company is confident that it will complete its takeover by ...
-
Article
Safilo continues to produce despite harsher lockdown measures
As its core business consists of making “medical devices,” Safilo has continued manufacturing both prescription frames and sunglasses in Italy despite harsher governmental regulations for the lockdown of non-essential activities in the country to stop the propagation of the Covid-19 virus. We could not determine at press time how many ...
